Solid Biosciences Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-54.8M | $-56.7M | $-45.8M | $-39.5M | $-39.3M | $-32.7M | $-25.1M | $-24.3M |
| Depreciation & Amortization | — | $395.0K | — | — | $407.0K | — | — | $327.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $5.2M | — | — | $3.3M | — | — | $1.6M |
| Net Cash from Operating Activities | $-52.6M | $-47.2M | $-33.5M | $-37.4M | $-31.9M | $-23.7M | $-21.5M | $-25.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $150.0K | $165.0K | $85.0K | $377.0K | $126.0K | $15.0K | $286.0K | $149.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $44.8M | — | — | $-27.5M | — | — | $-38.5M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $239.0M | — | — | $189.7M | — | — | $107.2M |
| Net Change in Cash | — | $236.6M | — | — | $130.4M | — | — | $43.6M |
| Free Cash Flow | $-52.7M | $-47.4M | $-33.6M | $-37.8M | $-32.0M | $-23.7M | $-21.8M | $-25.3M |